Benoît Delatour

Title: Benoît Delatour: Innovator in Cognitive Treatment

Introduction

Benoît Delatour is a notable inventor based in Cachan, France. He has made significant contributions to the field of cognitive treatment, particularly for individuals with Down syndrome. His innovative work has led to the development of a unique patent that addresses cognitive impairments.

Latest Patents

Delatour holds a patent for a composition and method aimed at treating cognitive impairments in subjects with Down syndrome. The patent details compounds that exhibit inverse agonist functional selectivity for GABA receptors containing the α5 subunit. These compounds are intended for use as a medicament to enhance cognitive function or to treat cognitive impairments in affected individuals. The pharmaceutical compositions may include these compounds or suitable pharmaceutically acceptable salts, along with polyethoxylated castor oil and dimethyl sulfoxide (DMSO). Methods for administering these compounds effectively to improve cognitive function are also disclosed in the patent.

Career Highlights

Throughout his career, Benoît Delatour has worked with prestigious organizations, including the Centre National de la Recherche Scientifique and F. Hoffmann-La Roche AG. His experience in these institutions has contributed to his expertise in cognitive research and pharmaceutical development.

Collaborations

Delatour has collaborated with notable colleagues such as Marie-Claude Potier and Robert H. Dodd. These partnerships have further enriched his research and innovation in the field.

Conclusion

Benoît Delatour's work in developing treatments for cognitive impairments in Down syndrome showcases his dedication to improving the lives of individuals affected by this condition. His innovative patent and collaborations highlight his significant contributions to medical science.